Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2026 07:00 ET | Source: Infex Therapeutics

Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections

Investment led by Jon Moulton supports progression of clinical and preclinical programmes addressing critical-priority pathogensInfex to present results from Phase IIa trial for first-in-class...
May 12, 2026 02:00 ET | Source: Infex Therapeutics

Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections

Investment led by Jon Moulton supports progression of clinical and preclinical programmes addressing critical-priority pathogensInfex to present results from Phase IIa trial for first-in-class...